| abstract |
This embodiment includes a method of treating a condition requiring the removal or destruction of cellular components, such as a benign tumor or a malignant tumor, using a small peptide-based compound in combination with an additional active agent. . In this method, the compound is administered intramuscularly, orally, intravenously, intrathecally, intraprostatically, intratumorally, intranasally, topically, transdermally, etc., to the required mammal alone or in combination with a carrier. Including, but not limited to. |